
Sanofi SNY
€ 38.40
0.29%
Geschäftsbericht 2025
hinzugefügt 14.03.2026
Sanofi Gesamtverbindlichkeiten 2011-2026 | SNY
Gesamtverbindlichkeiten Jährlich Sanofi
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 51.4 B | 53.6 B | 52.4 B | 41.6 B | 46.9 B | 44.1 B | 41.1 B | 39.1 B | 42.9 B | 43.8 B |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 53.6 B | 39.1 B | 45.7 B |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
390 M | $ 3.52 | -1.26 % | $ 1.05 B | ||
|
MorphoSys AG
MOR
|
1.98 B | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
395 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
5.38 M | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
7.89 M | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
119 M | $ 3.26 | 3.99 % | $ 229 M | ||
|
I-Mab
IMAB
|
707 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
62.5 M | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
6.61 M | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.45 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
20.4 M | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
126 M | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
7.8 M | - | 10.36 % | $ 9.8 M | ||
|
Aptorum Group Limited
APM
|
4.35 M | $ 0.79 | 0.04 % | $ 4.31 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.16 M | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
440 M | $ 4.13 | -1.67 % | $ 105 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
57.2 M | $ 6.39 | -3.62 % | $ 175 M | ||
|
argenx SE
ARGX
|
704 M | $ 705.24 | 0.28 % | $ 25 B | ||
|
Midatech Pharma plc
MTP
|
6.46 M | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
109 M | - | - | $ 86.2 M | ||
|
Alterity Therapeutics Limited
ATHE
|
5.89 M | $ 3.45 | -4.43 % | $ 8.3 B | ||
|
Ascendis Pharma A/S
ASND
|
1.47 B | $ 229.27 | -0.76 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
37.2 M | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
46.6 M | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
39.8 M | $ 6.07 | 0.33 % | $ 495 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.1 B | - | - | - | ||
|
Akero Therapeutics
AKRO
|
75.8 M | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
28.4 M | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
45.1 M | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
28.4 M | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
13.8 M | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
15.9 M | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
21.9 M | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
BioCardia
BCDA
|
4.59 M | $ 1.29 | 1.57 % | $ 27.3 M | ||
|
Anika Therapeutics
ANIK
|
42.3 M | $ 14.45 | 0.63 % | $ 212 M | ||
|
Aptinyx
APTX
|
28.4 M | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
14.7 M | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
59.5 M | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
7.43 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
93.3 M | $ 2.59 | -2.08 % | $ 16.3 M | ||
|
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
355 M | $ 1.5 | -0.99 % | $ 383 M | ||
|
Athira Pharma
ATHA
|
13.9 M | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
2.76 B | $ 94.98 | 4.9 % | $ 27.2 B | ||
|
CureVac N.V.
CVAC
|
470 M | - | - | $ 867 M | ||
|
Burford Capital Limited
BUR
|
1.45 B | $ 8.31 | 3.04 % | $ 1.34 B | ||
|
Aravive
ARAV
|
51.5 M | - | -13.39 % | $ 1.45 M | ||
|
AstraZeneca PLC
AZN
|
65.4 B | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
44.1 M | $ 1.15 | 3.6 % | $ 34.6 M |